Engineered Bio-inspired Multifunctional Peptide- and Protein-based Therapeutic Biomolecules for Better Wound Care.
Paramita GayenSomnath JanNilkanta ChowdhurySnehasish GhoshMonjuri HembramAngshuman BagchiRituparna Sinha RoyPublished in: Chemistry, an Asian journal (2021)
Developing non-immunogenic therapeutic biomolecules for facilitating blood clotting followed by wound healing via therapeutic angiogenesis, still remains a formidable challenge. Excessive blood loss of accident victims and battalions cause a huge number of deaths worldwide. Patients with inherited bleeding disorders face acute complications during injury and post-surgery. Biologically-inspired peptide-based hemostat can act as a potential therapeutic for handling coagulopathy. Additionally, non-healing wounds for patients having ischemic diseases can cause severe clinical complications. Advancement in stabilized growth-factor-based proangiogenic therapy may offer effective possibilities for the treatment of ischemic pathology. This review will discuss nature-inspired biocompatible stabilized peptide- and protein-based molecular medicines to serve unmet medical challenges for handling traumatic coagulopathy and impaired wound healing.
Keyphrases
- wound healing
- growth factor
- end stage renal disease
- healthcare
- newly diagnosed
- chronic kidney disease
- ejection fraction
- peritoneal dialysis
- minimally invasive
- risk factors
- drug induced
- drug delivery
- liver failure
- palliative care
- ischemia reperfusion injury
- stem cells
- endothelial cells
- atrial fibrillation
- coronary artery bypass
- patient reported outcomes
- surgical site infection
- ionic liquid
- body mass index
- respiratory failure
- pain management
- weight gain
- oxidative stress
- extracorporeal membrane oxygenation
- cancer therapy
- acute coronary syndrome
- affordable care act
- hepatitis b virus
- smoking cessation
- cell therapy